Diagnostic Yield of NGS Tests for Hereditary Ataxia: a Systematic Review
- 11 November 2023
- journal article
- review article
- Published by Springer Nature in The Cerebellum
- Vol. 23 (4) , 1552-1565
Abstract
Next-generation sequencing (NGS), comprising targeted panels (TP), exome sequencing (ES), and genome sequencing (GS) became robust clinical tools for diagnosing hereditary ataxia (HA). Determining their diagnostic yield (DY) is crucial for optimal clinical decision-making. We conducted a comprehensive systematic literature review on the DY of NGS tests for HA. We searched PubMed and Embase databases for relevant studies between 2016 and 2022 and manually examined reference lists of relevant reviews. Eligible studies described the DY of NGS tests in patients with ataxia as a significant feature. Data from 33 eligible studies showed a median DY of 43% (IQR = 9.5–100%). The median DY for TP and ES was 46% and 41.9%, respectively. Higher DY was associated with specific phenotype selection, such as episodic ataxia at 68.35% and early and late onset of ataxia at 46.4% and 54.4%. Parental consanguinity had a DY of 52.4% (p = 0.009), and the presumed autosomal recessive (AR) inheritance pattern showed 62.5%. There was a difference between the median DY of studies that performed targeted sequencing (tandem repeat expansion, TRE) screening and those that did not (p = 0.047). A weak inverse correlation was found between DY and the extent of previous genetic investigation (rho = − 0.323; p = 0.065). The most common genes were CACNA1A and SACS. DY was higher for presumed AR inheritance pattern, positive family history, and parental consanguinity. ES appears more advantageous due to the inclusion of rare genes that might be excluded in TP.Keywords
This publication has 43 references indexed in Scilit:
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventionsBMJ, 2016
- Next‐generation sequencing identifies novel CACNA1A gene mutations in episodic ataxia type 2Molecular Genetics & Genomic Medicine, 2016
- Molecular and clinical study of a cohort of 110 Algerian patients with autosomal recessive ataxiaBMC Medical Genetics, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Exome sequencing in undiagnosed inherited and sporadic ataxiasBrain, 2014
- Exome Sequencing in the Clinical Diagnosis of Sporadic or Familial Cerebellar AtaxiaJAMA Neurology, 2014
- Exome Sequencing as a Diagnostic Tool for Pediatric‐Onset AtaxiaHuman Mutation, 2013
- Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a modelBrain, 2013
- Best Practice Guidelines for the Use of Next-Generation Sequencing Applications in Genome Diagnostics: A National Collaborative Study of Dutch Genome Diagnostic LaboratoriesHuman Mutation, 2013
- Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyondThe Lancet Neurology, 2010